QUICK ANSWER
Coverage Overview
Short answer: Cigna coverage for Wegovy varies by plan. Some employer-sponsored plans cover it with prior authorization (sometimes with an optional Evernorth cost cap: $200/month cap (only if your employer adds it)), while many marketplace plans exclude weight loss medications. Medicare members can get Wegovy for weight loss through the Medicare GLP-1 Bridge, with conditions.
Is Wegovy covered by Cigna?
Most Cigna plans do not routinely cover Wegovy for weight loss. Coverage is most commonly available only when an employer has specifically opted into GLP-1 (a class of weight loss medications) benefits. Some plans may offer coverage under specific conditions:
- Some employer-sponsored commercial plans cover Wegovy with prior authorization, sometimes with a $200/month out-of-pocket cap
- Individual / ACA (Affordable Care Act) marketplace plans rarely cover weight loss medications
- Cigna Medicare Advantage plans' own drug benefit excludes Wegovy for weight loss (basic Part D coverage excludes weight-loss drugs by statute), but members can use the Medicare GLP-1 Bridge ($50 per monthly fill, with conditions)
Who this guide is for
Cigna members exploring Wegovy coverage through employer-sponsored commercial plans, ACA marketplace plans, Cigna Medicare Advantage, or Express Scripts-administered pharmacy benefits.
Why Cigna Coverage Varies by Employer and Plan
Cigna coverage differences are driven by who controls your benefits (employer vs insurer), how the plan is funded (fully insured vs self-funded), and your medical indication. This is why two Cigna members can receive very different coverage decisions, even within the same company.
- Large employers often control their own formularies (lists of covered drugs) and may add GLP-1 coverage
- Some plans now include the $200/month Evernorth cost cap
- Express Scripts administers the pharmacy benefits for most Cigna plans
To determine your exact coverage, check directly with Cigna. If you're denied, you still have options.
What to Know If You're Denied
Independent analyses suggest that a majority of properly documented appeals are overturned[3]—yet only about 1 in 10 patients ever appeal. Whether you've already been denied or are preparing for prior authorization, you still have options.
Denied already? See your appeal options →
Coverage Outlook for 2026
Cigna/Express Scripts coverage for Wegovy depends on whether your employer has opted into GLP-1 benefits. On Express Scripts' 2026 National Preferred Formulary, Wegovy and Zepbound single-dose pens are preferred; Zepbound vials, Zepbound KwikPens and Saxenda are excluded (if your plan covers weight-loss drugs at all), but whether weight-loss drugs are covered at all is up to your employer. The Evernorth cost-cap program is optional: $200/month cap (only if your employer adds it).
Last updated October 6, 2026 · Key facts verified October 5, 2026
Cigna Plans & Express Scripts
Unlike BCBS (which operates as 33 independent affiliates), Cigna operates nationally through Express Scripts, its pharmacy benefit manager (PBM).
Coverage is primarily determined by:
- Your Plan Type — large employer / small employer / individual / Medicare
- Express Scripts Formulary — whether your employer's plan includes GLP-1 coverage
Coverage varies by employer plan design, not by state. Call to check your coverage →
Pro tip: Calling can allow you to get more helpful information that isn't always available online.
Things to Keep in Mind
- Prior Auth is required — even when listed. Getting your full coverage details makes this a smoother process.
- If not covered — there are still different "exception" paths and options to consider.
- If denied, file an appeal — many properly documented appeals are overturned in national analyses.[3]
- Other indications can unlock coverage — such as Wegovy's cardiovascular risk reduction indication (Wegovy has no sleep apnea indication).
If this feels overwhelming, you're not alone — most people first learn their true coverage only after being denied once.
But coverage isn't the full story. Express Scripts administers most Cigna pharmacy benefits, and your plan type matters more than you might think.
See how Express Scripts affects your coverage →CIGNA'S PHARMACY BENEFIT MANAGER
Does Express Scripts Cover Wegovy?
Express Scripts is Cigna's pharmacy benefit manager (PBM). It administers the prescription drug formulary, prior authorization rules, and pharmacy claims processing for most Cigna plans.
Whether Express Scripts "covers" Wegovy depends entirely on your underlying Cigna plan:
| Your Plan Type | Express Scripts Shows | What It Means |
|---|---|---|
| Employer w/ GLP-1 coverage | "Covered with PA" | Your employer opted to cover it; PA required |
| Employer w/o GLP-1 coverage | "Not covered" | Your employer didn't add GLP-1 coverage |
| Individual / Marketplace | "Excluded" | Standard plans rarely cover weight loss drugs |
| Cigna Medicare (Part D) | Bridge: $50 per monthly fill (with conditions) | Federal statute excludes weight-loss drugs from basic Part D coverage; the Medicare GLP-1 Bridge is separate (outside Part D) |
How to Check Your Express Scripts Coverage
- Log into Express Scripts at express-scripts.com or the Express Scripts app
- Search for "Wegovy" in the drug lookup tool
- Review the result: "covered with prior authorization," "not covered," or "excluded"
- For confirmation, call the Member Services number on your Cigna ID card
Key Point
Express Scripts does not set independent coverage rules. It simply applies the pharmacy benefits defined by your Cigna plan. All the coverage criteria, prior authorization rules, and appeal steps on this page apply both to Cigna and to Express Scripts as the PBM.
Cigna's $200/Month Cap Program
In 2025, Cigna's Evernorth division announced a program that caps out-of-pocket costs for Wegovy and Zepbound at $200 per month on some employer-sponsored plans.[4][6]
- $200/month maximum for Wegovy and Zepbound
- Compared with self-pay ($349/month ($399 for Wegovy HD 7.2 mg)), the cap can lower monthly cost on higher-cost plans
- Simplified prior authorization designed to speed up access
- Available only if your employer opts in — not automatic for all Cigna plans
Questions to ask Cigna or HR:
- "Is my plan enrolled in the Evernorth $200/month GLP-1 cost cap?"
- "If so, does it apply to Wegovy specifically?"
Express Scripts answers depend on your plan type.
See how plan type affects coverage →PLAN + EMPLOYER RULESHow Plan Type Affects Your Coverage
How Plan Type Affects Your Coverage
Your Wegovy coverage is shaped by your plan type and employer decisions:
- Your Plan Type — who controls your benefits (your employer, Cigna, government)
- Employer Benefit Design — whether your employer added GLP-1 coverage
Think of it this way:
Cigna sets default formularies, but employers can customize them. Large employers often have more flexibility than small ones.
That's why two people with Cigna — even at the same company — can get different coverage if they chose different plan options.
Cigna Plan Types and Potential Coverage
| Your Plan Type | Chance of Coverage | Why |
|---|---|---|
| Large Employer (1,000+ employees) | Varies widely | Employer may control coverage; $200/mo cap on some plans |
| Small Employer (50–999 employees) | Usually excluded | Fully-insured plans less likely to include GLP-1s |
| Individual / ACA Marketplace | Rarely covered | Most individual plans exclude weight loss drugs |
| Cigna Medicare Advantage | Bridge only | By federal law, basic Part D coverage excludes weight-loss drugs; the Medicare GLP-1 Bridge (outside Part D) covers Wegovy for $50 per monthly fill (with conditions) |
Legend: Possible coverage · Usually excluded · Depends on employer plan design
More Details / Next Steps (Based on Plan Type)
Large Employer Plans — Often the Best Chance
Many large companies pay for healthcare themselves (this is called "self-funded"). Cigna just handles administration through Express Scripts.
That means your employer — not Cigna — decides whether drugs like Wegovy are covered.
Small Employer Plans — Usually No Coverage
Small employers usually buy standard Cigna plans with no customization. They must follow whatever Cigna's default formulary covers.
Individual / ACA Marketplace Plans — Rarely Covered
If you bought your plan through Healthcare.gov or directly from Cigna, it's a standard, non-customized plan. Weight-loss drugs are almost always excluded.
- Coverage through Wegovy's cardiovascular indication (or Ozempic for type 2 diabetes)
- Switching plans during open enrollment
- Self-pay options
Cigna Medicare Advantage — Bridge Only
If you're on Medicare, federal law excludes weight-loss drugs from basic Part D coverage, including the drug coverage in Medicare Advantage plans such as Cigna. The separate Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027) covers Wegovy for weight loss for $50 per monthly fill, with conditions.
- The Medicare GLP-1 Bridge for weight loss (Part D plans and pharmacies don’t opt in, and you don’t enroll separately; your prescriber must get prior authorization)
- Possible Part D coverage of Wegovy for cardiovascular risk reduction (adults with established cardiovascular disease and either obesity or overweight), subject to the plan’s formulary, prior authorization and exceptions process
- Coverage for type 2 diabetes (Mounjaro)
FIND YOUR PATHBased on Your Situation
Based on Your Situation
Now that you understand coverage patterns, here's what to do next:
PA Denied?
Your plan covers Wegovy, but your prior authorization was rejected.
- Submit complete documentation with your appeal
- You have 180 days to file an appeal
Plan Excludes It?
Wegovy isn't on your formulary (your plan's list of covered drugs) at all.
Exclusion options → Still Checking?
Haven't applied yet or want to understand your options first.
- Use our call script to verify with Cigna
- Check the 2026 outlook for coverage trends
Not Sure Which Applies? Check your denial letter.
- "Not medically necessary" or "step therapy required" (must try other treatments first) = PA denial (you can appeal)
- "Excluded benefit" or "not covered" = plan exclusion (different strategy needed)
WHAT'S COMING
Cigna Coverage Outlook for 2026
Generally Stable Coverage for 2026
Unlike some BCBS affiliates that are reducing GLP-1 coverage, Cigna and Express Scripts appear to be maintaining Wegovy on their 2026 formularies for plans that already cover obesity medications. The Evernorth $200/month cost-cap program may also expand to more employer plans.
What's Confirmed for 2026
- Coverage depends on your employer: On the 2026 Express Scripts National Preferred Formulary, Wegovy and Zepbound single-dose pens are preferred; Zepbound vials, Zepbound KwikPens and Saxenda are excluded (if your plan covers weight-loss drugs at all); whether weight-loss drugs are covered at all is up to the plan sponsor[8]
- $200/month cap is optional: The Evernorth cost-cap program launched in May 2025: $200/month cap (only if your employer adds it)[6]
- Medicare: The federal statute still excludes weight-loss drugs from basic Part D coverage[9], but the Medicare GLP-1 Bridge covers Wegovy for weight loss ($50 per monthly fill, July 1, 2026 – December 31, 2027), with conditions
What This Means for You
- Check your specific plan: Coverage depends on your employer's benefit design—don't assume
- During open enrollment: Ask HR if your employer is adding the $200/month cap or GLP-1 coverage
- Self-funded employers: Large employers can add or modify GLP-1 coverage at renewal
- Consider alternatives: If you have Type 2 diabetes, Ozempic (same active ingredient as Wegovy) may be covered for diabetes
CALL YOUR INSURANCEVerify Your Specific Coverage
Verify Your Specific Coverage
Even though it takes a little more time, we recommend calling so you can speak with a person who may have more information than the online directory or PDF formulary listing.
Call Script for Cigna
"Hi, I'm calling to check coverage for a prescription medication. My member ID is [NUMBER]. I need to know:
- Is Wegovy (semaglutide) covered on my plan's formulary for weight management?
- What tier is it on? (Tiers determine your copay—lower tier = lower cost)
- Is prior authorization required?
- What are the coverage criteria—BMI, health conditions, step therapy?
- Does my plan have the $200/month Evernorth cost cap for GLP-1s?
- Can you send me the coverage policy in writing?"
Pro tip: Always request coverage criteria in writing. Verbal confirmations aren't binding, and having documentation helps if you need to appeal later.
Cigna Contact Information
| Department | Phone Number | Use For |
|---|---|---|
| Member Services | Number on ID card | Coverage questions, benefits |
| Pharmacy Customer Service | 1-800-244-6224 | Prior authorization status, appeals[2] |
COMMON CRITERIA FOR WEGOVYPrior Authorization Requirements
Prior Authorization Requirements
When Cigna does cover Wegovy, prior authorization is always required. Key criteria from Cigna's GLP-1 Coverage Policy:[5]
- BMI (body mass index) ≥30 (or ≥27 with hypertension, type 2 diabetes, sleep apnea, cardiovascular disease)
- 3 months documented lifestyle efforts (diet and exercise in your medical record)
- No concurrent GLP-1 use — can't take Wegovy with Ozempic or other GLP-1 medications
- Renewal: Must lose 5% of starting weight to continue coverage
Cigna Decision Timelines
Medical services (not prescriptions) follow different review timelines; ask Cigna for the one that applies to your plan.
Renewal Requirement — Don't Miss This
Most Cigna plans require you to lose at least 5% of your starting body weight to continue coverage after the first authorization period (usually 6-12 months). If you don't meet this threshold, your renewal may be denied — even if the medication is working for you in other ways.
For complete documentation checklists and PA preparation: Wegovy Prior Authorization Guide →
YOUR PLAN COVERS ITIf Your PA Was Denied
If Your PA Was Denied
Your plan covers Wegovy, but the prior authorization was rejected. This is actually good news — over half of properly documented appeals succeed in national data.[3]
Common PA Denial Reasons
- Medical necessity not met → Medical Necessity Guide
- Step therapy required → Step Therapy Guide
- BMI criteria not met → BMI Criteria Guide
- Missing lifestyle documentation → Lifestyle Documentation Guide
Cigna Appeal Basics
- Deadline: 180 days from denial to file internal appeal
- Contact: Pharmacy Customer Service: 1-800-244-6224
- Tip: Submit via fax to get instant confirmation of receipt
For complete appeal strategies: Wegovy Appeals Guide → | External Review Process
Need help with your Cigna appeal? Start your free appeal review →
DIFFERENT STRATEGY NEEDEDIf Your Plan Excludes Wegovy
If Your Plan Excludes Wegovy
Wegovy isn't on your plan's drug list at all. Standard appeals won't work for a plan exclusion, but you have other options.
Your Options
- Request a formulary exception — your doctor can argue medical necessity → If Wegovy is not covered by your insurance
- Talk to HR — if you have employer insurance, ask if they can add GLP-1 coverage at renewal
- Switch plans during open enrollment — verify GLP-1 coverage in writing before switching
- Explore self-pay options — savings cards, NovoCare, and patient assistance may reduce costs → Wegovy Cost Guide
OSA Coverage: Zepbound vs Wegovy
Important Clarification: Wegovy Is NOT FDA-Approved for Sleep Apnea
On December 20, 2024, the FDA approved Zepbound (tirzepatide)—not Wegovy—as the first medication for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity.[1]
If You Have Sleep Apnea
Wegovy has no FDA approval for sleep apnea; with no OSA indication, an OSA coverage route doesn’t apply to Wegovy at Cigna.
Option for OSA: If OSA is your primary concern, consider Zepbound—the only GLP-1 with FDA approval for OSA. See Cigna Zepbound coverage →
Have an Employer Plan? Talk to HR
If you have insurance through your employer, your HR/Benefits department may be able to help:
- Self-funded employers (typically larger companies) can modify coverage—they're not bound by standard Cigna rules
- Ask HR to advocate for adding GLP-1 coverage at the next plan renewal
- Request the $200/month Evernorth cap be added if your plan doesn't have it
CIGNA WEGOVY COVERAGE
Frequently Asked Questions
It depends on your Cigna plan. Express Scripts is Cigna's pharmacy benefit manager (PBM)—it administers pharmacy benefits but doesn't set independent coverage rules. Whether Express Scripts shows Wegovy as "covered" depends entirely on your Cigna plan design. Employer plans with GLP-1 coverage will show it as covered with prior authorization; plans without GLP-1 coverage will show "not covered."
Some Cigna plans do, but many do not. Coverage depends on your specific plan type. Employer-sponsored commercial plans are most likely to include coverage, especially large self-funded employers. Individual marketplace and Medicare Advantage plans typically exclude weight loss medications. In 2025, Cigna introduced a $200/month out-of-pocket cap on select employer plans.
When Cigna covers Wegovy, typical PA requirements include: BMI ≥30 or ≥27 with a comorbidity (hypertension, type 2 diabetes, OSA, or cardiovascular disease), 3 months of documented lifestyle modification (diet and exercise program), and you cannot be taking another GLP-1 medication simultaneously. For renewals, you must show at least 5% weight loss.
When covered, Wegovy is typically placed on Tier 4 (non-preferred specialty), which means higher out-of-pocket costs. However, plans with the $200/month Evernorth cap can limit these costs even at Tier 4. Prior authorization is always required regardless of tier.
You have 180 days to file an internal appeal. Request the denial in writing with the specific reason, then submit an appeal through the Cigna member portal (myCigna.com), by fax, or by mail. Include supporting documentation like a Letter of Medical Necessity and clinical evidence. Your doctor can also request a peer-to-peer review. If the internal appeal fails, you can request a binding external review within 4 months (at least; check your state).
Not through the plan's own drug benefit—but Cigna Medicare Advantage members can use the Medicare GLP-1 Bridge. Basic Medicare Part D coverage excludes weight-loss drugs by federal statute; the separate Bridge (July 1, 2026 – December 31, 2027), which runs outside Part D, covers Wegovy for weight loss for $50 per monthly fill if you meet CMS's criteria and your prescriber gets prior authorization. Important: Wegovy is NOT FDA-approved for sleep apnea—that approval went to Zepbound (tirzepatide) in December 2024. If you have OSA, Zepbound may be a better option as it has the FDA indication.
In May 2025, Cigna's Evernorth division launched an optional benefit that caps patient out-of-pocket costs for Wegovy and Zepbound: $200/month cap (only if your employer adds it). It's only available on employer plans that adopt the program—ask your HR department or call Cigna to check if your plan includes it.
YOUR PATH FORWARD
What's Next
Wegovy Coverage: Other Major Insurers
See how other insurers compare on Wegovy coverage:
- UnitedHealthcare — Coverage varies by plan; many require PA
- Blue Cross Blue Shield — Major 2026 coverage restrictions announced
- Aetna — Most plans cover with prior authorization
- Anthem Blue Cross — Separate policies from other BCBS affiliates
- Humana — Medicare and Medicaid plans only; Medicare members can use the Medicare GLP-1 Bridge
Other GLP-1 Medications at Cigna
Cigna's coverage varies by medication. Compare your options:
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get startedAppeal outcomes are not guaranteed and depend on your specific plan and documentation.
References
- FDA. (December 20, 2024). "FDA Approves First Medication for Obstructive Sleep Apnea." Note: This approval was for Zepbound (tirzepatide), not Wegovy. Wegovy is not FDA-approved for OSA. fda.gov
- Cigna Healthcare. (2025). "Prescription Drug Lists and Coverage." cigna.com
- American Medical Association / KFF Analysis. (2024). "Over 80% of Prior Auth Appeals Succeed—Why Aren't There More?" ama-assn.org
- Drug Topics. (2025). "Evernorth Benefit Option Will Cap Wegovy, Zepbound Monthly Cost at $200." May 22, 2025. drugtopics.com
- Cigna Healthcare. (2025). "Weight Loss – Glucagon-Like Peptide-1 Agonists Prior Authorization Criteria." Cigna National Formulary Coverage Policy. static.cigna.com [PDF]
- Evernorth Health Services. (2025). "Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month." May 21, 2025. evernorth.com
- Cigna Healthcare. (2025). "What is Prior Authorization?" Standard prescription drug reviews completed within 72 hours; expedited within 24 hours. cigna.com
- Express Scripts. (2025). "National Preferred Formulary (NPF) FAQ." 2026 NPF: Wegovy and Zepbound single-dose pens are preferred; Zepbound vials, Zepbound KwikPens and Saxenda are excluded (if your plan covers weight-loss drugs at all); coverage of weight-loss drugs is up to the plan sponsor. express-scripts.com
- Congressional Research Service. (2024). "Medicare Coverage of GLP-1 Drugs." Medicare Modernization Act of 2003 excludes drugs used for weight loss from Part D coverage. congress.gov
- Honest Care. (2025). "GLP-1 Patient Access Report (Q3/Q4 2025)." Analysis of 1,000+ U.S. GLP-1 denial cases across all major insurers. findhonestcare.com
Last updated October 6, 2026 · Key facts verified October 5, 2026
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.